U.S. flag

An official website of the United States government

NM_001034853.2(RPGR):c.905G>C (p.Cys302Ser) AND Primary ciliary dyskinesia

Germline classification:
Benign (2 submissions)
Last evaluated:
Jan 25, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001079787.9

Allele description [Variation Report for NM_001034853.2(RPGR):c.905G>C (p.Cys302Ser)]

NM_001034853.2(RPGR):c.905G>C (p.Cys302Ser)

Gene:
RPGR:retinitis pigmentosa GTPase regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xp11.4
Genomic location:
Preferred name:
NM_001034853.2(RPGR):c.905G>C (p.Cys302Ser)
HGVS:
  • NC_000023.11:g.38304664C>G
  • NG_009553.1:g.27872G>C
  • NM_000328.3:c.905G>C
  • NM_001034853.2:c.905G>CMANE SELECT
  • NM_001367245.1:c.902G>C
  • NM_001367246.1:c.905G>C
  • NM_001367247.1:c.905G>C
  • NM_001367248.1:c.935G>C
  • NM_001367249.1:c.902G>C
  • NM_001367250.1:c.902G>C
  • NM_001367251.1:c.905G>C
  • NP_000319.1:p.Cys302Ser
  • NP_001030025.1:p.Cys302Ser
  • NP_001354174.1:p.Cys301Ser
  • NP_001354175.1:p.Cys302Ser
  • NP_001354176.1:p.Cys302Ser
  • NP_001354177.1:p.Cys312Ser
  • NP_001354178.1:p.Cys301Ser
  • NP_001354179.1:p.Cys301Ser
  • NP_001354180.1:p.Cys302Ser
  • NC_000023.10:g.38163917C>G
  • NM_000328.2:c.905G>C
  • NR_159803.1:n.1047G>C
  • NR_159804.1:n.956G>C
  • NR_159805.1:n.1047G>C
  • NR_159806.1:n.1047G>C
  • NR_159807.1:n.1047G>C
Protein change:
C301S
Links:
dbSNP: rs62640590
NCBI 1000 Genomes Browser:
rs62640590
Molecular consequence:
  • NM_000328.3:c.905G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001034853.2:c.905G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001367245.1:c.902G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001367246.1:c.905G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001367247.1:c.905G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001367248.1:c.935G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001367249.1:c.902G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001367250.1:c.902G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001367251.1:c.905G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_159803.1:n.1047G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_159804.1:n.956G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_159805.1:n.1047G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_159806.1:n.1047G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_159807.1:n.1047G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
1

Condition(s)

Name:
Primary ciliary dyskinesia
Synonyms:
Ciliary dyskinesia
Identifiers:
MONDO: MONDO:0016575; MedGen: C0008780; OMIM: PS244400; Human Phenotype Ontology: HP:0012265

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001003962Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Benign
(Jan 25, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002687686Ambry Genetics
criteria provided, single submitter

(Ambry General Variant Classification Scheme_2022)
Benign
(Sep 10, 2015)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided1not providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV001003962.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Ambry Genetics, SCV002687686.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown1not providednot provided1not providednot providednot provided

Last Updated: Apr 15, 2024